Live corpus
Active intelligence prompt Pediatric cancer: surface high-value therapeutic signals across pediatric oncology literature.
PEDIATRIC CANCER RESEARCH INTELLIGENCE

Finding therapies hidden in 40,255 pediatric cancer papers.

Neurocompute scores pediatric oncology literature, surfaces overlooked therapeutic signals, and turns fragmented childhood cancer research into a living discovery terminal.

40,255 Papers indexed
1,440 Papers AI scored
40,255 Ranked papers
100.0% Coverage
PATIENT-FRIENDLY SUMMARY

CHIP-AML22: a complex clinical trial in de novo pediatric AML patients, including a gemtuzumab ozogamicin randomization and targeted therapy with quizartinib in eligible subgroups, within the NOPHO-DB-SHIP consortium.

For education only—not personal medical advice.

LIVE PEDIATRIC ONCOLOGY INTELLIGENCE
↑ Therapeutic signals emerging ↑ New pediatric cancer papers ingested ↑ Cross-paper convergence detected ↑ Human relevance scores updating ↑ Overlooked treatment paths surfacing
TOP PEDIATRIC CANCER SIGNALS

Ranked Discovery Journal Articles

View all discoveries →
LATEST PEDIATRIC CANCER PAPERS

Database feed

Last ingest 2026-11-09 10:15 AM
PEDIATRIC CANCER RESEARCH TERMINAL

All ranked pediatric cancer papers

40255 results
D
Pediatric Spitzoid Melanoma: A Case Report.
PMID 41268742 Published: 2025-12-01 Ingested: 2026-08-02 12:05 AM Acta medica academica
AI -
Standard 52.3
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 52.3/100. Study design: 30.0; human relevance: 80.0; therapeutic relevance: 34.0; sample size: 20.0; recency: 100.0; abstract quality: 85.0.

D
Primary Intracranial Sarcoma, DICER1-Mutant, Diagnosed by DNA Methylation Profiling in an Adult Patient with Germline DICER1 Mutation: A Case Report.
PMID 41236848 Published: 2025-11-14 Ingested: 2026-08-02 12:05 AM International journal of surgical pathology
AI -
Standard 52.3
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 52.3/100. Study design: 30.0; human relevance: 80.0; therapeutic relevance: 44.0; sample size: 20.0; recency: 100.0; abstract quality: 65.0.

AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 52.3/100. Study design: 30.0; human relevance: 80.0; therapeutic relevance: 34.0; sample size: 20.0; recency: 100.0; abstract quality: 85.0.

D
Coexistence of Immune Thrombocytopenic Purpura and Bernard-Soulier Syndrome: A Rare Pediatric Case Report.
PMID 41195296 Published: 2025-10-31 Ingested: 2026-08-02 12:03 AM International medical case reports journal
AI -
Standard 52.3
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 52.3/100. Study design: 30.0; human relevance: 80.0; therapeutic relevance: 34.0; sample size: 20.0; recency: 100.0; abstract quality: 85.0.

D
The Baffling Diagnosis of a Rare Case of Polypoid Endometriosis: Neoplasm Mimicking in a Young Pregnant Woman-A Case Report and Literature Review.
PMID 41095679 Published: 2025-09-26 Ingested: 2026-08-02 12:05 AM Diagnostics (Basel, Switzerland)
AI -
Standard 52.3
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 52.3/100. Study design: 30.0; human relevance: 80.0; therapeutic relevance: 34.0; sample size: 20.0; recency: 100.0; abstract quality: 85.0.

D
Uncommon Localization of Tenosynovial Giant Cell Tumor in the Coracoclavicular Ligament: Diagnostic Challenges.
PMID 41091649 Published: 2025-10-15 Ingested: 2026-08-02 12:05 AM The American journal of case reports
AI -
Standard 52.3
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 52.3/100. Study design: 30.0; human relevance: 80.0; therapeutic relevance: 34.0; sample size: 20.0; recency: 100.0; abstract quality: 85.0.

D
AI -
Standard 52.3
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 52.3/100. Study design: 50.0; human relevance: 55.0; therapeutic relevance: 39.0; sample size: 20.0; recency: 100.0; abstract quality: 65.0.

AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 52.3/100. Study design: 30.0; human relevance: 80.0; therapeutic relevance: 34.0; sample size: 20.0; recency: 100.0; abstract quality: 85.0.

D
Pterional dermal sinus: case report and review of the literature.
PMID 40999207 Published: 2025-09-26 Ingested: 2026-08-02 12:05 AM Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery
AI -
Standard 52.3
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 52.3/100. Study design: 30.0; human relevance: 80.0; therapeutic relevance: 34.0; sample size: 20.0; recency: 100.0; abstract quality: 85.0.

D
Coexistence of IDH1 Mutation and KIAA1549::BRAF Fusion in a Diffuse Glioma: A Case Report With Clinical, Radiological, and Pathological Correlation.
PMID 40968574 Published: 2025-10-01 Ingested: 2026-08-02 12:05 AM Neuropathology : official journal of the Japanese Society of Neuropathology
AI -
Standard 52.3
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 52.3/100. Study design: 30.0; human relevance: 80.0; therapeutic relevance: 34.0; sample size: 20.0; recency: 100.0; abstract quality: 85.0.

D
Histopathological crossover between unicystic ameloblastoma and odontogenic keratocyst in 12-year-old: a case report with literature review.
PMID 40958008 Published: 2025-09-16 Ingested: 2026-08-02 12:05 AM European archives of paediatric dentistry : official journal of the European Academy of Paediatric Dentistry
AI -
Standard 52.3
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 52.3/100. Study design: 30.0; human relevance: 80.0; therapeutic relevance: 34.0; sample size: 20.0; recency: 100.0; abstract quality: 85.0.

Previous
Page 2823 of 3355
Next
Before you continue

AI-assisted research information

Neurocompute uses AI to summarize scientific papers, interpret research signals, and suggest relevant reference links. AI-generated content can be incomplete, misleading, or wrong, and generated links may be irrelevant or unavailable.

Our reviewed outputs have performed strongly to date, but past accuracy is not a guarantee. Verify summaries, scores, claims, and links against the original publication before relying on them.

This platform is for research and education only. It does not provide medical advice, diagnosis, treatment recommendations, or clinical guidance.

Pediatric cancer research intelligence graphic
PEDIATRIC CANCER VISUAL SYSTEM

Open the Research Intelligence Map

Explore the active pediatric oncology analysis view.

Expand Intelligence View →
Full Pediatric cancer research intelligence graphic